Silodosin Recordati Eiropas Savienība - latviešu - EMA (European Medicines Agency)

silodosin recordati

recordati ireland ltd - silodosin - prostatas hiperplāzija - urologicals, alfa-adrenoreceptor antagonistiem - Ārstēšanu, simptomi un pazīmes, labdabīgas prostatas hiperplāzijas (bph) pieauguši vīrieši.

Tinidazol-Polpharma 500 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

tinidazol-polpharma 500 mg apvalkotās tabletes

pharmaceutical works polpharma sa, poland - tinidazols - apvalkotā tablete - 500 mg

Dexketoprofen Sopharma 50 mg/2 ml šķīdums injekcijām/infūzijām Latvija - latviešu - Zāļu valsts aģentūra

dexketoprofen sopharma 50 mg/2 ml šķīdums injekcijām/infūzijām

sopharma ad, bulgaria - deksketoprofēns - Šķīdums injekcijām/infūzijām - 50 mg/2 ml

Celecoxib Zentiva 100 mg cietās kapsulas Latvija - latviešu - Zāļu valsts aģentūra

celecoxib zentiva 100 mg cietās kapsulas

zentiva, k.s., czech republic - celekoksibs - kapsula, cietā - 100 mg

Celecoxib Zentiva 200 mg cietās kapsulas Latvija - latviešu - Zāļu valsts aģentūra

celecoxib zentiva 200 mg cietās kapsulas

zentiva, k.s., czech republic - celekoksibs - kapsula, cietā - 200 mg

Bortezomib PharmaSwiss 3,5 mg pulveris injekciju šķīduma pagatavošanai Latvija - latviešu - Zāļu valsts aģentūra

bortezomib pharmaswiss 3,5 mg pulveris injekciju šķīduma pagatavošanai

pharmaswiss ceska republika s.r.o., czech republic - bortezomibs - pulveris injekciju šķīduma pagatavošanai - 3,5 mg

Ketoprofen Sopharma 25 mg/g gels Latvija - latviešu - Zāļu valsts aģentūra

ketoprofen sopharma 25 mg/g gels

sopharma ad, bulgaria - ketoprofēns - gels - 25 mg/g

Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Eiropas Savienība - latviešu - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - klopidogrela hidrohlorīds - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotiskie līdzekļi - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Metoclopramid Polpharma 10 mg/2 ml šķīdums injekcijām Latvija - latviešu - Zāļu valsts aģentūra

metoclopramid polpharma 10 mg/2 ml šķīdums injekcijām

pharmaceutical works polpharma sa, poland - metoklopramīda hidrohlorīds - Šķīdums injekcijām - 10 mg/2 ml

Paracetamol Sopharma 500 mg tabletes Latvija - latviešu - Zāļu valsts aģentūra

paracetamol sopharma 500 mg tabletes

sopharma ad, bulgaria - paracetamols - tablete - 500 mg